Key social, clinical and programmatic factors were associated with loss to follow-up and death during tuberculosis treatment among people with HIV. Addressing these vulnerabilities is essential to improving treatment outcomes and advancing progress towards the 2030 targets.
Lima et al. (Wed,) studied this question.